天天舔天天爽_视频日韩_成人网线_天天草草草_免费一级在线观看_色综合色综合色综合色综合

美國Beckman Coulter Agencourt    
Agencourt公司的主營產(chǎn)品為用于生化醫(yī)療研究的核酸純化產(chǎn)品，這些產(chǎn)品采用了Agencourt公司獨有的固相可逆固定化學(xué)（SPRI）技術(shù)。據(jù)貝克曼公司相關(guān)人士介紹，SPRI技術(shù)可適用于對超過三分之一的人類基因進行測序的樣品制備方面。
Agencourt reagents, accessories, and software methods coupled with Beckman Coulter automation, create an unparalleled alignment of automation proficiency. Agencourt reagents are based on the SPRI technology, which is ideal for automating on the Biomek Laboratory Automation Workstations. By utilizing the Agencourt SPRI-based reagents and Beckman Coulter’s automation hardware, Agencourt’s software methods were developed to allow for easy robot configuration and intuitive user-interface. Beckman Coulter’s Agencourt Automation Solutions enable faster throughput and higher quality results.
Agencourt Bioscience Corporation is a trusted provider of genomic services and nucleic acid purification products. We are dedicated to designing solutions for overcoming all of our clients' current and future discovery challenges.

Discovery Solutions
Agencourt's Discovery Solutions suite of genomic and functional genomic services enable biotechnology, pharmaceutical, government and academic research laboratories to develop new and more effective drugs. Our genomic services pipeline sets our facility apart and is based on our patented SPRI technology. Agencourt also offers an array of SPRI-based nucleic acid purification products for customers who wish to improve and automate their own genetic and genomic discovery initiatives.

Vision & Values
Agencourt uses the most advanced technologies to offer its clients a wide array of services that encompass the full scope of biotechnology's needs. We believe that building a world-class operation is critical to our success. Our commitment to operational excellence allows us to quickly and securely deliver the highest quality results to our clients. We are an extension of our client's laboratory by providing outsourcing solutions with the quality and trust expected from an in-house provider